Premium
Some evidence for hypnotic in reducing suicidality in depressed adults with insomnia
Publication year - 2020
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30520
Subject(s) - suicidal ideation , placebo , serotonin reuptake inhibitor , hypnotic , insomnia , psychiatry , medicine , antidepressant , zolpidem , psychology , clinical psychology , poison control , suicide prevention , anxiety , alternative medicine , medical emergency , pathology
Eight weeks of treatment with controlled‐release zolpidem in conjunction with a selective serotonin reuptake inhibitor (SSRI) antidepressant generated mixed results relative to placebo on measures of suicidal ideation in depressed suicidal adults with insomnia. Use of the hypnotic resulted in improvement over placebo on one measure of suicidal ideation but not on a second measure, the researchers found.